MedTrace Logo

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes

NCT01265836 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 1064

Last updated 2011-04-12

No results posted yet for this study

Summary

The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment (statin or combination) reaching the LDL-C goals according to the updated 2004 National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Apichard Sukonthasarn, Prof.M.D. · Maharaj Nakorn Chiangmai Hospital Cardiovascular division, Department of Internal Medicine, Faculty of Medicine, Chiangmai University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01265836 on ClinicalTrials.gov